Archive for the ‘Profiles’ Category

Right Turn: Andrew Pelling Redux

Author: Stacey Johnson, 08/12/16

August 10, 2016 | UOttawa professor and TED Fellow is the keynote speaker for the 2016 Undergraduate Summer Research Program (USRP) Symposium. Here’s what our community members had to say on social media:

Stem cell community loses a treasured friend

Author: Guest, 01/18/16

Joe Sornberger is Director of Communications Programs for the Canadian Stem Cell Foundation and author of Dreams & Due Diligence: Till and McCulloch’s Stem Cell Discovery and Legacy. This post is published here with his permission. The stem cell community is mourning the loss of one of its most cherished champions, Andrew David Lyall. Mr. Lyall…Read more

Studying the brain needs an “open mind”

Author: Hamideh Emrani, 10/21/15

Another in the series: “What Drives Research in the Field of Biomaterials?” The amazingly complex system of the brain, and its network of many different cell types interacting and functioning together, has always been “top of mind” – pardon the pun – for many researchers. It is just a little over 10 years since Professor…Read more

What drives research in the field of biomaterials? Second in series

Author: Guest, 05/11/15

. An interview with Professor John E. Davies, University of Toronto. By Hamideh Emrani The second post, in my interview series with biomaterials experts, is with my Master’s supervisor, Professor John (JED) Davies. He is an internationally recognized leader in bone biomaterials, a serial entrepreneur, and a Professor at the University of Toronto’s Institute of…Read more

What drives research in the field of biomaterials?

Author: Guest, 04/22/15

. By Hamideh Emrani It always feels amazing to find a solution to a problem or challenge. I think this huge sense of accomplishment is what drives many people in the research community. During my academic career, I have come across some remarkable scientists and researchers who thrive on problem solving. I find it intriguing…Read more

Such a long journey – Europe approves retinal cell therapy based on decades of good science

Author: David Kent, 03/24/15

> At one of my very first Canadian Stem Cell Network Annual General Meetings, when I was just a couple of years into my stem cell biology training, I remember sitting down just after lunch when a jovial Italian man sauntered up to the stage and apologized to the audience for the timing of his…Read more

Right Turn: Why you should vote for Stem Cell Person of the Year

Author: Lisa Willemse, 10/10/14

> We assume there is no real argument to be made here. It’s more than just popularity or who has been in the news most often over the past year. The annual call for nominations and the selection of Stem Cell Person of the Year by readers of Paul Knoepfler’s blog – a.k.a. the stem cell…Read more

Right Turn: No passport required for new animation on stem cell tourism

Author: Ben Paylor, 06/20/14

> Following the initial success of our award-winning StemCellShorts animation project, we are happy to launch the next video in the series. This video features Prof. Timothy Caulfield narrating a response to the question: “What is stem cell tourism?” We were lucky to be able to record the narration with Tim in the idyllic Rocky…Read more

Right Turn: Stripping down to the muscle

Author: Lisa Willemse, 03/28/14

> Michael Rudnicki has been studying muscle biology for a long time… all the way back to his days as a graduate student. In this time, he’s contributed greatly to our understanding about muscle formation and the molecular “switches” that guide a stem cell’s decision to develop down the pathway towards muscle or brown fat….Read more

“Freedom to operate” strategy positions BioTime for rapid growth

Author: Paul Krzyzanowski, 12/16/13

> This is part three of an interview series with Michael West, CEO of BioTime. Read parts one and two.  The prospects for BioTime and other companies that operate in the tissue engineering and cell therapy market are good. The industry is growing by about 18% per year and is estimated to reach $11 billion…Read more